Clinical Trials Browser

Phase 1/2 × Withdrawn × tivozanib × Clear all

NCT01728181 2013-07-25

A Phase I/II Study of Tivozanib and Erlotinib as Initial Treatment for Metastatic Non-small Cell Lung Cancer Assigned by VeriStrat® Serum Proteomic Evaluation

Phase 1/2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Disease